Searched for
BARICITINIB
Study reveals arthritis drug can suppress progression of type 1 diabetesThe drug was found to safely preserve the body's insulin production and suppress the advancement of type 1 diabetes when initiated within 1...- Which medicine works best for Covid-19 treatment? WHO answersFor those infected, it is important to know your best treatment options -- the right medicines and drugs that have been effective in reduci...
- ICMR to conduct clinical trial for evaluation of COVID-19 therapy with Oxford UniversityAccording to the ICMR, the intervention arm of the trial will include baricitinib and the control arm will receive local standard of care. ...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drugUnder the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary li...
- MSN Labs launches black fungus drug Posaconazole in IndiaMSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...
- BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drugBaricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...
- Top experts finds no proof baricitinib works against CovidExperts are of the view that the clinicians can use it in their wisdom, but decided against recommending the drug in the national guideline...
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- MSN Labs ties up with Eli Lilly for baricitinib in IndiaAs part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...
- Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drugThe Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...
- Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in IndiaAs the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements th...
- India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19Baricitinib has been given restricted emergency use approval by India's drug regulator for use in combination with remdesivir for the treat...
- Covid drug: Natco eyes patent waiverIn its application, Natco has cited the unmet medical needs due to the lack of supply and affordability in light of the grave and life-thre...
- Covid drug: Natco eyes patent waiverMaking its case, Natco’s application said Olumiant is not manufactured in India — less than 9,000 tablets were imported in 2019 and 2020, a...
- Natco gets emergency use nod for Baricitinib to treat Covid without trialsIn a statement, the Hyderabad headquartered pharma company said Baricitinib in combination with Remdesivir is used for the treatment of Cov...
- Natco Seeks emergency approval to launch Molnupiravir for Covid-19 in IndiaMolnupiravir was originally developed to treat influenza before US-based Merck initiated research to repurpose drug for use against SARS-Co...
- SEC denies emergency nod to Natco Covid-19 drugNatco had in December sought a waiver of the clinical trial requirement for the emergency use of baricitinib tablets in Covid-19 treatment,...
- Hyderabad-based Natco Pharma wants to make Eli Lilly’s Covid drugNatco has sought nod for the manufacture and marketing of baricitinib bulk drug and tablets in 1 to 4 mg versions in India. This move may t...
- Eli Lilly receives permission to conduct Phase 3 clinical trials for Covid treatmentThe Subject Expert Committee (SEC) that advises the drug regulatory authority on new drugs, vaccines for Covid gave its permission to the c...
Load More
